We’re proud to once again be ranked in the top five of Americas Most Just companies in biopharma. The honor reflects our ongoing commitment to operate responsibly and empower our employees to help create a healthier world for all.
In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her approach to developing new medicines and to bringing Gilead closer to a cure for HIV.
Lauren Huffmaster received a late-stage metastatic breast cancer (mBC) diagnosis in 2015 and soon discovered there wasn’t a lot information to help explain to her young children what she was going through.
Each scientific discovery gets us one step closer to our shared goal of ending the HIV epidemic. As a leader in HIV treatment and prevention, we’ll continue to build on our legacy and create innovative solutions to address the diverse needs of all people affected by HIV.
As a nation where 90% of all people living with HIV know their diagnosis and are being treated, Germany has made great strides to advance its HIV care goals.
Gilead HIV Policy Directors Dan Murphy and Pema McGuinness recently developed a series of policy papers that warn of the consequences if governments fail to take steps to prioritize and invest in HIV.
As the ninth of 13 children, Dr. Carmen J. Walters grew up in New Orleans, where her father built houses during the day and worked at the railroad at night, and her mother did a variety of jobs, such as cooking for local schools.
The SABCS brings the scientific community and advocates together to focus on the biggest needs in breastcancer, including how the disease uniquely affects Black women.
Meet Brent Allan, a long-time HIV advocate in Australia who advises Gilead Sciences regarding programs that would best serve the needs of people living with HIV.
Gilead Sciences ranked No. 6 overall, and No. 2 within the Health Care & Life Sciences industry, in Newsweek’s just-released list of Most Responsible American Companies.
Gilead Sciences is proud to be added to the Dow Jones Sustainability World Index, part of S&P Global Dow Jones Indices, based on our performance on the Corporate Sustainability Assessment.
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...